Cell migration inhibition activity of a non-RGD disintegrin from Crotalus durissus collilineatus venom
Tóm tắt
In recent decades, snake venom disintegrins have received special attention due to their potential use in anticancer therapy. Disintegrins are small and cysteine-rich proteins present in snake venoms and can interact with specific integrins to inhibit their activities in cell-cell and cell-ECM interactions. These molecules, known to inhibit platelet aggregation, are also capable of interacting with certain cancer-related integrins, and may interfere in important processes involved in carcinogenesis. Therefore, disintegrin from Crotalus durissus collilineatus venom was isolated, structurally characterized and evaluated for its toxicity and ability to interfere with cell proliferation and migration in MDA-MB-231, a human breast cancer cell line. Based on previous studies, disintegrin was isolated by FPLC, through two chromatographic steps, both on reversed phase C-18 columns. The isolated disintegrin was structurally characterized by Tris-Tricine-SDS-PAGE, mass spectrometry and N-terminal sequencing. For the functional assays, MTT and wound-healing assays were performed in order to investigate cytotoxicity and effect on cell migration in vitro, respectively. Disintegrin presented a molecular mass of 7287.4 Da and its amino acid sequence shared similarity with the disintegrin domain of P-II metalloproteases. Using functional assays, the disintegrin showed low cytotoxicity (15% and 17%, at 3 and 6 μg/mL, respectively) after 24 h of incubation and in the wound-healing assay, the disintegrin (3 μg/mL) was able to significantly inhibit cell migration (24%, p < 0.05), compared to negative control. Thus, our results demonstrate that non-RGD disintegrin from C. d. collilineatus induces low cytotoxicity and inhibits migration of human breast cancer cells. Therefore, it may be a very useful molecular tool for understanding ECM-cell interaction cancer-related mechanisms involved in an important integrin family that highlights molecular aspects of tumorigenesis. Also, non-RGD disintegrin has potential to serve as an agent in anticancer therapy or adjuvant component combined with other anticancer drugs.
Tài liệu tham khảo
Kini RM, Evans HJ. Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon. 1992;30(3):265–93.
Calvete JJ. The continuing saga of snake venom disintegrins. Toxicon. 2013;62:40–9.
Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem. 1987;262(33):16157–63.
Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JJ, et al. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med. 1990;195(2):168–71.
Selistre-de-Araujo HS, Pontes CLS, Montenegro CF, Martin ACBM. Snake venom disintegrins and cell migration. Toxins (Basel). 2010;2(11):2606–21.
Sanchez EF, Flores-Ortiz RJ, Alvarenga VG, Eble JA. Direct fibrinolytic snake venom metalloproteinases affecting hemostasis: structural, biochemical features and therapeutic potential. Toxins (Basel). 2017;9:12.
Calvete JJ, Jürgens M, Marcinkiewicz C, Romero A, Schrader M, Niewiarowski S. Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin α5β1 antagonist from Eristocophis macmahoni venom. Biochem J. 2000;345(3):573–81.
Bilgrami S, Yadav S, Kaur P, Sharma S, Perbandt M, Betzel C, et al. Crystal structure of the disintegrin heterodimer from saw-scaled viper (Echis carinatus) at 1.9 a resolution. Biochemistry. 2005;44(33):11058–66.
Bilgrami S, Tomar S, Yadav S, Kaur P, Kumar J, Jabeen T, et al. Crystal structure of schistatin, a disintegrin homodimer from saw-scaled viper (Echis carinatus) at 2.5 a resolution. J Mol Biol. 2004;341(3):829–37.
Calvete JJ, Moreno-Murciano MP, Theakston RD, Kisiel DG, Marcinkiewicz C. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J. 2003;372(Pt 3):725–34.
Juárez P, Comas I, González-Candelas F, Calvete JJ. Evolution of snake venom disintegrins by positive Darwinian selection. Mol Biol Evol. 2008;25(11):2391–407.
Sanz L, Bazaa A, Marrakchi N, Pérez A, Chenik M, Bel Lasfer Z, et al. Molecular cloning of disintegrins from Cerastes vipera and Macrovipera lebetina transmediterranea venom gland cDNA libraries: insight into the evolution of the snake venom integrin-inhibition system. Biochem J. 2006;395(2):385–92.
Calvete JJ, Juárez P, Sanz L. Snake venomics and disintegrins: portrait and evolution of a family of snake venom integrin antagonists. In: Mackessy SP, editor. Handbook of venoms and toxins of reptiles. Boca Ratón: CRC Press, Taylor & Francis; 2009. p. 337–57.
Calvete JJ. Brief history and molecular determinants of snake venom disintegrin evolution. In: Kini RM, Markland F, McLane MA, Morita T, editors. Toxins and hemostasis: from bench to bedside. Amsterdam: Springer; 2010. p. 285–300.
Oshikawa K, Terada S. Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. J Biochem. 1999;125(1):31–5.
Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, et al. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem. 1991;266(15):9359–62.
Hite LA, Shannon JD, Bjarnason JB, Fox JW. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal, zymogen, and disintegrin-like structures. Biochemistry. 1992;31(27):6203–11.
King GF. Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther. 2011;11(11):1469–84.
O’Shea JC, Tcheng JE. Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa. Expert Opin Pharmacother. 2002;3(8):1199–210.
Menozzi A, Merlini PA, Ardissino D. Tirofiban in acute coronary syndromes. Expert Rev Cardiovasc Ther. 2005;3(2):193–206.
Arruda Macêdo JK, Fox JW, de Souza Castro M. Disintegrins from snake venoms and their applications in cancer research and therapy. Curr Protein Pept Sci. 2015;16(6):532–48.
Zhou Q, Sherwin RP, Parrish C, Richters V, Groshen SG, Tsao-Wei D, et al. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Res Treat. 2000;61(3):249–60.
Kim KS, Kim DS, Chung KH, Park YS. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes. Cancer Gene Ther. 2006;13(6):563–71.
Higuchi DA, Almeida MC, Barros CC, Sanchez EF, Pesquero PR, Lang EA, et al. Leucurogin, a new recombinant disintegrin cloned from Bothrops leucurus (white-tailed-jararaca) with potent activity upon platelet aggregation and tumor growth. Toxicon. 2011;58(1):123–9.
Wang JH, Wu Y, Ren F, Lü L, Zhao BC. Cloning and characterization of Adinbitor, a novel disintegrin from the snake venom of Agkistrodon halys brevicaudus stejneger. Acta Biochim Biophys Sin Shanghai. 2004;36(6):425–9.
Tian J, Paquette-Straub C, Sage EH, Funk SE, Patel V, Galileo D, et al. Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin. Toxicon. 2007;49(7):899–908.
Galán JA, Sánchez EE, Rodríguez-Acosta A, Soto JG, Bashir S, McLane MA, et al. Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox. Toxicon. 2008;51(7):1186–96.
Zakraoui O, Marcinkiewicz C, Aloui Z, Othman H, Grépin R, Haoues M, et al. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression. Mol Carcinog. 2017;56(1):18–35.
Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9–22.
Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis. 2010;32(1–2):35–48.
Zhao F, Li L, Guan L, Yang H, Wu C, Liu Y. Roles for GP IIb/IIIa and αvβ3 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction. Cancer Lett. 2014;344(1):62–73.
Calvete JJ, Juarez P, Sanz L. Snake venomics. Strategy and applications. J Mass Spectrom. 2007;42:1405–14.
Shagger H, von Jagow G. Tricine-SDS-PAGE for the separation of proteins in the 1–100 kDa range. Anal Biochem. 1987;168:368–79.
Edman P, Begg G. A protein sequenator. Eur J Biochem. 1967;1(1):80–91.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–10.
The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017;45:D158–69.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. J Immunol Methods. 1983;65:55–63.
Oliveira IS, Cardoso IA, KCF B, Carone SEI, Boldrini-França J, Pucca MB, et al. Global proteomic and functional analysis of Crotalus durissus collilineatus individual venom variation and its impact on envenoming. J Proteome. 2018.
Boldrini-Franca J, Corrêa-Netto C, Silva MMS, Rodrigues RS, De La Torre P, Perez A, et al. Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management. J Proteome. 2010;73(9):1758–76.
Nicolau CA, Carvalho PC, Junqueira-de-Azevedo IL, Teixeira-Ferreira A, Junqueira M, Perales J, et al. An in-depth snake venom proteopeptidome characterization: benchmarking Bothrops jararaca. J Proteome. 2017;151:214–31.
Zhou Q, Hu P, Ritter MR, Swenson SD, Argounova S, Epstein AL, et al. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom. Arch Biochem Biophys. 2000;375(2):278–88.
Suntravat M, Helmke TJ, Atphaisit C, Cuevas E, Lucena SE, Uzcátegui NL, et al. Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion. Toxicon. 2016;122:43–9.
Suntravat M, Barret HS, Jurica CA, Lucena SE, Perez JC, Sánchez EE. Recombinant disintegrin (r-cam-dis) from Crotalus adamanteus inhibits adhesion of human pancreatic cancer cell lines to laminin-1 and vitronectin. J Venom Res. 2015;6:1–10.
Saviola AJ, Modahl CM, Mackessy SP. Disintegrins of Crotalus simus tzabcan venom: isolation, characterization and evaluation of the cytotoxic and anti-adhesion activities of tzabcanin, a new RGD disintegrin. Biochimie. 2015;116:92–102.
Angulo Y, Castro A, Lomonte B, Rucavado A, Fernández J, Calvete JJ, et al. Isolation and characterization of four medium-size disintegrins from the venoms of central American viperid snakes of the genera Atropoides, Bothrops, Cerrophidion and Crotalus. Biochimie. 2014;107(Pt B):376–84.
Moritz MNO, Eustáquio LMS, Micocci KC, Nunes ACC, Dos Santos PK, de Castro Vieira T, et al. Alternagin-C binding to α2β1 integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells. J Venom Anim Toxins incl Trop Dis. 2018;24:13. https://doi.org/10.1186/s40409-018-0150-2.
Boldrini-França J, Rodrigues RS, Fonseca FP, Menaldo DL, Ferreira FB, Henrique-Silva F, et al. Crotalus durissus collilineatus venom gland transcriptome: analysis of gene expression profile. Biochimie. 2009;91(5):586–95.
Calvete JJ, Schäfer W, Soszka T, Lu WQ, Cook JJ, Jameson BA, et al. Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity. Biochemistry. 1991;30(21):5225–9.
Huang TF, Holt JC, Kirby EP, Niewiarowski S. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry. 1989;28(2):661–6.
Knudsen KA, Tuszynski GP, Huang TF, Niewiarowski S. Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Exp Cell Res. 1988;179(1):42–9.
Saudek V, Atkinson RA, Lepage P, Pelton JT. The secondary structure of echistatin from 1H-NMR, circular-dichroism and Raman spectroscopy. Eur J Biochem. 1991;202(2):329–38.
Calvete JJ, Wang Y, Mann K, Schäfer W, Niewiarowski S, Stewart GJ. The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett. 1992;309(3):316–20.
Chan YS, Cheung RCF, Xia L, Wong JH, Ng TB, Chan WY. Snake venom toxins: toxicity and medicinal applications. Appl Microbiol Biotechnol. 2016;100(14):6165–81.
Ferraz FB, Fernandez JF. Integrinas na adesão, migração e sinalização celular: associação com patologias e estudos clínicos. Revista Científica da FMC. 2014;9(2):25–34 http://www.fmc.br/revista/V9N2P25-34.pdf.
Hou S, Isaji T, Hang Q, Im S, Fukuda T, Gu J. Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells. Sci Rep. 2016;6:18430.
Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer. 2004;90(3):561–5.
Gui GP, Puddefoot JR, Vinson GP, Wells CA, Carpenter R. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg. 1995;82(9):1192–6.
Taherian A, Li X, Liu Y, Haas TA. Differences in integrin expression and signaling within human breast cancer cells. BMC Cancer. 2011;11:293.
Saviola AJ, Burns PD, Mukherjee AK, Mackessy SP. The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells. Int J Biol Macromol. 2016;88:457–64.
Hammouda MB, Montenegro MF, Sánchez-del-Campo L, Zakraoui O, Aloui Z, Riahi-Chebbi I, et al. Lebein, a snake venom disintegrin, induces apoptosis in human melanoma cells. Toxins (Basel). 2016;8(7):1–14.
Lucena S, Castro R, Lundin C, Hofstetter A, Alaniz A, Suntravat M, et al. Inhibition of pancreatic tumoral cells by snake venom disintegrins. Toxicon. 2015;93:136–43.
Czarnomysy R, Surażyński A, Popławska B, Rysiak E, Pawłowska N, Czajkowska A, et al. Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells. Mol Cell Biochem. 2017;427(1):13–22.